Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line Treatment-Reference-Cited by-同舟云学术

Drug Resistance Among Adolescents and Young Adults with Virologic Failure of First-Line Antiretroviral Therapy and Response to Second-Line Treatment

Published:2020-07-01 Issue:7 Volume:36 Page:566-573
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

Kouamou Vinie¹,Varyani Bhavini²,Shamu Tinei³,Mapangisana Tichaona⁴,Chimbetete Cleophas³⁵,Mudzviti Tinashe³⁶,Manasa Justen⁷,Katzenstein David²⁸

Affiliation:

1. Department of Medicine, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

2. Department of Molecular Biology, Biomedical Research and Training Institute, Harare, Zimbabwe.

3. Newlands Clinic, Newlands, Harare, Zimbabwe.

4. Division of Epidemiology and Biostatistics, University of Stellenbosch, Stellenbosch, South Africa.

5. Institute of Global Health, University of Geneva, Geneva, Switzerland.

6. School of Pharmacy, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

7. Department of Medical Microbiology, College of Health Sciences, University of Zimbabwe, Harare, Zimbabwe.

8. Department of Medicine, Stanford University School of Medicine, Stanford, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/aid.2019.0232

Reference59 articles.

1. Antiretroviral treatment and quality of life in Africans living with HIV: 12-month follow-up in Burkina Faso

2. Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda

3. Safety and Efficacy of a 36-Week Induction Regimen of Abacavir/Lamivudine and Ritonavir-Boosted Atazanavir in HIV-Infected Patients

4. Cost-effectiveness analysis of tenofovir/emtricitabine and abacavir/lamivudine in combination with efavirenz or atazanavir/ritonavir for treatment-naïve adults with HIV-1 infection in the UK, based on the AIDS Clinical Trials Group 5202 clinical trial

5. 7. World Health Organization:Treat all: Policy adoption and implementation status in countries: Fact sheet. Geneva, Switzerland: World Health Organization, Department of HIV/AIDS.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence of human immunodeficiency virus drug resistance and factors associated with high viral load among adolescents on antiretroviral therapy in Dar Es Salaam, Tanzania;HIV Research & Clinical Practice;2024-09-08

2. Strengthening and enhancing national antiretroviral drug resistance surveillance in Zimbabwe—A country that has reached UNAIDS 95-95-95 amongst adults;Frontiers in Public Health;2024-02-14

3. Virological, weight, and drug resistance outcomes among patients initiating a dolutegravir-based first-line antiretroviral therapy regimen in Zimbabwe;AIDS;2024-01-16

4. Added Value of Next Generation Sequencing in Characterizing the Evolution of HIV-1 Drug Resistance in Kenyan Youth;Viruses;2023-06-22

5. HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania;PLOS ONE;2023-02-23